Education
About Us
Working with TipRanks
Follow Us
InDex Pharmaceuticals Holding AB (SE:FLERIE)
:FLERIE
RESEARCH TOOLSreports
FLERIE Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr37.21 - kr51.51
Previous CloseN/A
Volume1.84K
Average Volume (3M)37.24K
Market Cap
kr3.55B
Enterprise Valuekr2.79B
Total Cash (Recent Filing)kr802.10M
Total Debt (Recent Filing)kr800.00K
Price to Earnings (P/E)0.3
Beta-0.04
Next Earnings
Jul 31, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.21
Shares Outstanding78,066,410
10 Day Avg. Volume8,544
30 Day Avg. Volume37,243
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)0.91
Price to Sales (P/S)0.00
P/FCF Ratio-2.37K
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
kr45.04Price Target Upside-3.96% Downside
Rating ConsensusHold
Number of Analyst Covering0
FLERIE FAQ
What was InDex Pharmaceuticals Holding AB’s price range in the past 12 months?
InDex Pharmaceuticals Holding AB lowest stock price was kr37.21 and its highest was kr51.51 in the past 12 months.
What is InDex Pharmaceuticals Holding AB’s market cap?
InDex Pharmaceuticals Holding AB’s market cap is kr3.55B.
When is InDex Pharmaceuticals Holding AB’s upcoming earnings report date?
InDex Pharmaceuticals Holding AB’s upcoming earnings report date is Jul 31, 2025 which is in 12 days.
How were InDex Pharmaceuticals Holding AB’s earnings last quarter?
Currently, no data Available
Is InDex Pharmaceuticals Holding AB overvalued?
According to Wall Street analysts InDex Pharmaceuticals Holding AB’s price is currently Overvalued.
Does InDex Pharmaceuticals Holding AB pay dividends?
InDex Pharmaceuticals Holding AB does not currently pay dividends.
What is InDex Pharmaceuticals Holding AB’s EPS estimate?
InDex Pharmaceuticals Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InDex Pharmaceuticals Holding AB have?
InDex Pharmaceuticals Holding AB has 78,066,410 shares outstanding.
What happened to InDex Pharmaceuticals Holding AB’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of InDex Pharmaceuticals Holding AB?
Currently, no hedge funds are holding shares in SE:FLERIE
Company Description
InDex Pharmaceuticals Holding AB
InDex Pharmaceuticals Holding AB (FLERIE) is a pharmaceutical company focused on the development of treatments for immunological diseases. The company's primary focus is on its lead product candidate, cobitolimod, designed to treat moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. InDex Pharmaceuticals operates in the biotechnology sector, aiming to address unmet medical needs through innovative therapies.
Technical Analysis
Hansa Biopharma AB
―
BioInvent International AB
―
Vicore Pharma Holding AB
―
Xspray Pharma AB
―
SynAct Pharma AB
―